Psychiatry

Lower LDL cholesterol linked to reduced dementia risk

by

The Intersection of Cholesterol Management and Dementia Prevention Recent studies continue to reveal intriguing connections between cholesterol management and dementia prevention. Amid growing concerns about the increasing prevalence of dementia, understanding how low-density lipoprotein cholesterol (LDL-C) levels influence cognitive health is pivotal. The latest research, published in the Journal of Neurology, Neurosurgery & Psychiatry, provides … Read more

Rivaroxaban Akin to Warfarin for Left Ventricular Thrombus After MI

by

The Promising Horizon of Anticoagulation: A Look at Rivaroxaban vs. Warfarin Anticoagulants have long played a pivotal role in managing conditions like myocardial infarction (MI) by preventing the formation of dangerous blood clots in the heart. The recent RIVAWAR trial sheds new light on rivaroxaban as a significant contender against warfarin, a standard treatment in … Read more

Intensive Medical Therapy Does Not Improve Outcomes in Women with INOCA

by

The WARRIOR Trial: A Landmark Study in Women’s Heart Health The recent conclusion of the WARRIOR trial has turned heads in the medical community, particularly among specialists treating ischemia without obstructive coronary artery disease (INOCA). Conducted as the largest randomized, pragmatic outcome trial for INOCA, the study has provided critical insights yet with a nuance … Read more

Prior Oral Anticoagulant Use May Influence Stroke, Bleeding Risk in AF

by

Exploring the Future of Anticoagulant Treatments for Atrial Fibrillation New Insights from OCEANIC-AF Study The recent findings from the Oral Factor 11a Inhibitor Asundexian as Novel Antithrombotic–Atrial Fibrillation (OCEANIC-AF) study opened up new possibilities in treating atrial fibrillation (AF) patients. Atrial fibrillation is a common heart condition led by irregular heartbeats, increasing the risk of … Read more

Novel Lipid Indicator Identifies Risk of Ischemic Heart Disease in T2D

by

Unlocking the Future of Lipid Management in Type 2 Diabetes A groundbreaking investigation has unveiled a potential game-changer in assessing ischemic heart disease (IHD) risks for individuals with type 2 diabetes (T2D): the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR). Led by Sikun Zhang of the Second Xiangya Hospital, this study highlights how … Read more

HCPLive 5 Stories in Under 5: Week of 03/16

by

Future Trends in Healthcare: Insights from Recent Developments Advancements in Migraine Treatment Protocols The recent update from the American College of Physicians (ACP) on adding a triptan to NSAIDs or acetaminophen for treating migraines marks a significant shift in acute migraine management. This combination therapy approach could influence new treatment algorithms across healthcare systems. Clinicians, … Read more

Nearly half of depression patients struggle with treatment resistance

by

Understanding the Scope of Treatment-Resistant Depression Recent research from the University of Birmingham highlights a concerning trend: nearly half of patients diagnosed with depression are treatment-resistant. This condition, known as treatment-resistant depression (TRD), is marked by a lack of response to at least two different antidepressants. With 37% of patients having tried four or more … Read more

With March Madness, the growth of online betting draws more concern

by

The Soaring Surge in Online Gambling: A March Madness Phenomenon The NCAA March Madness tournament is not just a high-octane spectacle for college basketball fans; it is now a massive catalyst for online betting, drawing in more wagers than ever before. With Americans projected to bet a record-breaking $3.1 billion this year, up from $2.7 … Read more

HCPLive 5 Stories in Under 5: Week of 03/09

by

Revolutionizing Weight Management: The Future of CagriSema The recent success of CagriSema in the Phase 3 REDEFINE 2 trial has marked a significant milestone in weight management for individuals with obesity and type 2 diabetes. As CagriSema demonstrated a nearly 16% weight loss, exceeding placebo results, we are poised to see how this regorafenib will … Read more

Hepatology Month in Review: February 2025

by

Future Trends in Hepatology: Innovations and Insights As we delve deeper into the strides made in hepatology during 2025, several groundbreaking developments promise to revolutionize liver disease management. Let’s explore the potential trends shaping the future of hepatology. Advancements in Drug Approvals and Liver Disease Management The US Food and Drug Administration’s recent endorsement of … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: office@newsy-today.com

For contact, advertising, copyright, issues email: office@newsy-today.com